<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.1012445</article-id><article-id pub-id-type="publisher-id">ACM-39203</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20201200000_10453228.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  血清miR-223预测多发性骨折患者术后感染的临床价值分析
  Clinical Value Analysis of Serum miR-223 in Predicting Postoperative Infection of Multiple Fractures Patients
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>刚刚</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>加良</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>臧</surname><given-names>正</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>海宁</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>诸城市桃园卫生院，山东 潍坊</addr-line></aff><aff id="aff2"><addr-line>青岛大学附属医院关节外科，山东 青岛</addr-line></aff><aff id="aff4"><addr-line>诸城市人民医院，山东 潍坊</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>12</month><year>2020</year></pub-date><volume>10</volume><issue>12</issue><fpage>2953</fpage><lpage>2959</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：本研究旨在探讨多发性骨折术后感染患者中血清miR-223的表达水平，并对其诊断价值进行评估。方法：选取于我院收治的120例多发性骨折患者，根据术后感染情况，分为感染组(n = 65)和非感染组(n = 55)。通过qRT-PCR对患者术前血清miR-223及C-反应蛋白(CRP)的表达水平进行检测。通过绘制受试者工作特征曲线对其诊断价值进行评估。结果：多发性骨折术后感染组患者血清miR-223表达水平显著低于非感染组。血清miR-223预测多发性骨折术后感染的受试者工作特征曲线下面积(AUC)为0.822，灵敏度和特异度分别为84.6%和74.5%。血清CRP预测多发性骨折患者术后感染的AUC为0.812，灵敏度和特异度分别为76.9%和72.7%。血清miR-223和CRP联合诊断的AUC为0.928，敏感度(96.4%)和特异度(76.9%)均高于单一指标的诊断结果。结论：血清miR-223在多发性骨折术后感染的患者中低表达，可能是预测多发性骨折术后感染的一个潜在的生物标志物。血清miR-223和CRP联合诊断能够提高诊断的准确性。
    Aim: This study aimed to investigate the expression levels of miR-223 in the serum of multiple fractures patients with postoperative infection, and assess its diagnostic value. Methods: 120 multiple fractures patients were selected, and divided into infection group (n = 65) and non-infection group (n = 55). Serum levels of miR-223 and C-reactive protein (CRP) were detected by using qRT-PCR. The receiver operating characteristics (ROC) curves were plotted to evaluate the diagnostic value. Results: Multiple fractures patients in postoperative infection group had high levels of miR-223 than those in non-infection group. The areas under receiver operating characteristics curves (AUC) of serum miR-223 in predicting infection after reoperation was 0.822, with the sensitivity of 84.6% and specificity of 74.5%. The AUC of serum CRP in predicting infection after reoperation was 0.812, with the sensitivity of 76.9% and specificity of 72.7%. The AUC of serum miR-223 combined with CRP reached up to 0.928, with the sensitivity of 96.4% and the specificity of 76.9%, which were higher than that of the diagnostic value of a single index. Conclusion: miR-223 was low-expressed in the serum of multiple fracture patients with postoperative infections, and might be a promising biomarker for predicting postoperative infection after multiple fractures. The combined detection of serum miR-223 and CRP might improve the diagnostic efficacy. 
  
 
</p></abstract><kwd-group><kwd>多发性骨折，术后感染，miR-223，C-反应蛋白，联合诊断, Multiple Fractures</kwd><kwd> Postoperative Infections</kwd><kwd> miR-223</kwd><kwd> C-Reactive Protein</kwd><kwd> Combined Detection</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：本研究旨在探讨多发性骨折术后感染患者中血清miR-223的表达水平，并对其诊断价值进行评估。方法：选取于我院收治的120例多发性骨折患者，根据术后感染情况，分为感染组(n = 65)和非感染组(n = 55)。通过qRT-PCR对患者术前血清miR-223及C-反应蛋白(CRP)的表达水平进行检测。通过绘制受试者工作特征曲线对其诊断价值进行评估。结果：多发性骨折术后感染组患者血清miR-223表达水平显著低于非感染组。血清miR-223预测多发性骨折术后感染的受试者工作特征曲线下面积(AUC)为0.822，灵敏度和特异度分别为84.6%和74.5%。血清CRP预测多发性骨折患者术后感染的AUC为0.812，灵敏度和特异度分别为76.9%和72.7%。血清miR-223和CRP联合诊断的AUC为0.928，敏感度(96.4%)和特异度(76.9%)均高于单一指标的诊断结果。结论：血清miR-223在多发性骨折术后感染的患者中低表达，可能是预测多发性骨折术后感染的一个潜在的生物标志物。血清miR-223和CRP联合诊断能够提高诊断的准确性。</p></sec><sec id="s2"><title>关键词</title><p>多发性骨折，术后感染，miR-223，C-反应蛋白，联合诊断</p></sec><sec id="s3"><title>Clinical Value Analysis of Serum miR-223 in Predicting Postoperative Infection of Multiple Fractures Patients<sup> </sup></title><p>Ganggang Wang<sup>1</sup>, Jialiang Zhang<sup>2</sup>, Zheng Zang<sup>3</sup>, Haining Zhang<sup>1*</sup></p><p><sup>1</sup>Department of Joint Surgery, The Affiliated Hospital of Qingdao University, Qingdao Shandong</p><p><sup>2</sup>Zhucheng Taoyuan Hospital, Weifang Shandong</p><p><sup>3</sup>Zhucheng People’s Hospital, Weifang Shandong</p><p><img src="//html.hanspub.org/file/15-1571705x5_hanspub.png" /></p><p>Received: Nov. 21<sup>st</sup>, 2020; accepted: Dec. 10<sup>th</sup>, 2020; published: Dec. 17<sup>th</sup>, 2020</p><p><img src="//html.hanspub.org/file/15-1571705x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Aim: This study aimed to investigate the expression levels of miR-223 in the serum of multiple fractures patients with postoperative infection, and assess its diagnostic value. Methods: 120 multiple fractures patients were selected, and divided into infection group (n = 65) and non-infection group (n = 55). Serum levels of miR-223 and C-reactive protein (CRP) were detected by using qRT-PCR. The receiver operating characteristics (ROC) curves were plotted to evaluate the diagnostic value. Results: Multiple fractures patients in postoperative infection group had high levels of miR-223 than those in non-infection group. The areas under receiver operating characteristics curves (AUC) of serum miR-223 in predicting infection after reoperation was 0.822, with the sensitivity of 84.6% and specificity of 74.5%. The AUC of serum CRP in predicting infection after reoperation was 0.812, with the sensitivity of 76.9% and specificity of 72.7%. The AUC of serum miR-223 combined with CRP reached up to 0.928, with the sensitivity of 96.4% and the specificity of 76.9%, which were higher than that of the diagnostic value of a single index. Conclusion: miR-223 was low-expressed in the serum of multiple fracture patients with postoperative infections, and might be a promising biomarker for predicting postoperative infection after multiple fractures. The combined detection of serum miR-223 and CRP might improve the diagnostic efficacy.</p><p>Keywords:Multiple Fractures, Postoperative Infections, miR-223, C-Reactive Protein, Combined Detection</p><disp-formula id="hanspub.39203-formula6"><graphic xlink:href="//html.hanspub.org/file/15-1571705x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/15-1571705x8_hanspub.png" /> <img src="//html.hanspub.org/file/15-1571705x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>多发性骨折是指由同一个致病因素引起的两处及以上的骨折的发生。多发性骨折的患者伤情复杂，抵抗力较为低下，容易引发术后感染，因此具有病情变化快、死亡率高的特点 [<xref ref-type="bibr" rid="hanspub.39203-ref1">1</xref>]。对患者可能的术后感染情况进行及时准确的评估及干预治疗，是降低患者死亡率的有效途径。目前，主要通过临床症状表现对患者的术后感染情况进行鉴别诊断，而患者伤口的正常愈合往往能够掩盖其感染的临床症状，对临床感染的诊断起到一定的迷惑性，从而影响诊断的准确性。近年来，血清标记物在多种疾病中被大量挖掘，引起了国内外学者的广泛关注 [<xref ref-type="bibr" rid="hanspub.39203-ref2">2</xref>]。多个术后感染的血清标志物也被报道，如血清原降钙素(procalcitonin, PCT)、c反应蛋白(C-reactive protein, CRP)等 [<xref ref-type="bibr" rid="hanspub.39203-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.39203-ref4">4</xref>]。但是其在术后感染中的诊断特异性和敏感性存在争议 [<xref ref-type="bibr" rid="hanspub.39203-ref5">5</xref>]。因此，更高敏感度和特异度的诊断标志物的筛选仍是当下研究的重点。</p><p>近年来，一种新型生物标志物，循环microRNAs (miRNAs)，在各种疾病中被广泛报道。miRNAs是一类小型的非编码RNA，在细胞的多个过程中发挥着重要的作用。miRNAs在血清或血浆中稳定表达，低浓度的RNA就足以用于血清miRANs差异表达谱的筛选构建 [<xref ref-type="bibr" rid="hanspub.39203-ref6">6</xref>]。miRNAs在不同疾病中的表达模式和功能，有助于血清miRNAs临床价值的评估和应用 [<xref ref-type="bibr" rid="hanspub.39203-ref7">7</xref>]。microRNA-223 (miR-223)是一种造血特异性microRNA，在髓系发育中具有重要功能 [<xref ref-type="bibr" rid="hanspub.39203-ref8">8</xref>]。据报道，miR-223在多种疾病中异常表达，通过靶向不同的靶基因来调节机体炎症反应，进而参与疾病的进展，如败血症、类风湿性关节炎、病毒感染(如人类免疫缺陷病毒1 (HIV-1))等 [<xref ref-type="bibr" rid="hanspub.39203-ref9">9</xref>]。miR-223在脓毒症患者中异常表达，被认为是一种新的脓毒症的血清生物标志物 [<xref ref-type="bibr" rid="hanspub.39203-ref10">10</xref>]。在一项非小细胞肺癌的研究中，miR-223被检测到在术后患者的血清中显著降低，推测其可能参与了术后的疾病恢复进程 [<xref ref-type="bibr" rid="hanspub.39203-ref11">11</xref>]。因此，miR-223在多发性骨折患者术后感染中的临床价值引起了我们的兴趣。</p><p>因此，本研究共纳入120例多发性骨折患者，并通过qRT-PCR检测miR-223在患者血清中的表达水平。旨在探讨多发性骨折术后感染患者中血清miR-223的表达水平变化，并对其诊断价值进行评估，拟为多发性骨折二次术后感染的诊断以及治疗提供一定的理论依据。</p></sec><sec id="s6"><title>2. 材料与方法</title><sec id="s6_1"><title>2.1. 研究对象</title><p>选取于我院收治的120例多发性骨折患者，根据术后感染情况，分为感染组和非感染组。患者的术后感染状况通过临床查体、影像学检查、实验室检查及病原菌培养进行确诊，均符合《医院感染诊断标准(试行)》要求 [<xref ref-type="bibr" rid="hanspub.39203-ref12">12</xref>]。患者排除标准：1) 年龄小于18周岁；2) 病理性骨折及非外伤引起的骨折；3) 严重肝、肾疾病；4) 恶性肿瘤；5) 自身免疫疾病、血液疾病、肺结核、有机磷中毒及肝脏暴力损伤的患者。感染组中共有男性50例，女性15例，平均年龄47.62 &#177; 10.20；在致伤原因方面，39例为交通事故，14例为高空坠落，12例为重物压伤。非感染组中共有男性41例，女性14例，平均年龄46.75 &#177; 9.36；在致伤原因方面，29例为交通事故，16例为高空坠落，10例为重物压伤。</p><p>本研究所有患者均签署了知情同意书，并经过青岛大学医学部临床医学院医学伦理委员会的审查批准。</p></sec><sec id="s6_2"><title>2.2. 样本采集</title><p>所有患者入院时对患者的临床信息进行收集，并记录病史。患者于术前一天清晨，收集静脉血3 ml，血液样本在无菌乙二胺四乙酸(ethylene diamine tetraacetic acid, EDTA)试管中分离，随后离心15分钟，收集血型，于−80℃冰箱保存备用。</p></sec><sec id="s6_3"><title>2.3. RNA提取及实时荧光定量PCR</title><p>根据说明书的要求，使用TRIzol (Invitrogen, USA)进行总RNA提取。使用逆转录试剂盒进行反转录，得到cDNA。扩增反应在ABI 7300 qRT-PCR仪上进行，使用SYBR green I Master Mix试剂盒(Invitrogen, USA)进行反应。反应条件为：95℃ 15 min；94℃ 15 s；55℃ 30 s；70℃ 34 s，共40个循环。以U6作为miRNA表达量的内参，且其相对表达量用2−ΔΔCt的方法进行计算。引物序列如下：miR-223 forward：5’-GCAGCCTGTCAGTTTGTCA-3’，reverse：5’-CGCTTCACGAATTTGCGTGTCAT-3’；U6 forward：5’-GCTTCGGCAGCACATATACTAAAAT-3’，reverse：5’-CGCTTCACGAATTTGCGTGTCAT-3’。</p></sec><sec id="s6_4"><title>2.4. 统计学分析</title><p>本实验所有数据和分析均采用SPSS 21.0软件进行。组间计量资料通过独立样本t测验进行组间比较，计数资料进行卡方检验。通过绘制受试者工作特征曲线(receiver operating characteristic, ROC)，对其诊断价值进行评估，选取约登指数最大时为最佳筛选界值。所有数据当P &lt; 0.05时认为差异具有统计学意义。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 人口及临床资料</title><p>表1结果显示，感染组和非感染组患者在年龄、性别、损伤严重程度、致伤原因、合并糖尿病等临床资料方面，差异不显著。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographic and clinical characteristics between group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >变量</th><th align="center" valign="middle" >非感染组 (n = 55)</th><th align="center" valign="middle" >感染组 (n = 65)</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >年龄</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.287</td></tr><tr><td align="center" valign="middle" >≥60</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;60</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >性别</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.762</td></tr><tr><td align="center" valign="middle" >男性</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >女性</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >损伤严重程度评分</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.863</td></tr><tr><td align="center" valign="middle" >16~32</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;32</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >致伤原因</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.619</td></tr><tr><td align="center" valign="middle" >交通</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >高空坠物</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >重物压伤</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >合并糖尿病</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.871</td></tr><tr><td align="center" valign="middle" >有</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >无</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>表1. 组间的人口统计学和临床特征</p></sec><sec id="s7_2"><title>3.2. 患者血清CRP及miR-223水平</title><p>通过独立样本t测验，对两组患者的血清CRP和miR-223水平进行了比较分析，结果显示，术前感染组的患者血清CRP水平显著高于非感染组，而血清miR-223水平则显著低于非感染组(表2)。</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Comparison of serum CRP and miR-223 levels of patients before the reoperatio</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >指标</th><th align="center" valign="middle" >非感染组 (n = 55)</th><th align="center" valign="middle" >感染组 (n = 65)</th><th align="center" valign="middle" >P值</th></tr></thead><tr><td align="center" valign="middle" >CRP (mg/L)</td><td align="center" valign="middle" >23.416 &#177; 6.738</td><td align="center" valign="middle" >31.497 &#177; 6.112</td><td align="center" valign="middle" >&lt;0.001</td></tr><tr><td align="center" valign="middle" >miR-223</td><td align="center" valign="middle" >0.786 &#177; 0.246</td><td align="center" valign="middle" >0.494 &#177; 0.200</td><td align="center" valign="middle" >&lt;0.001</td></tr></tbody></table></table-wrap><p>表2. 术前患者血清CRP及miR-223水平比较</p></sec><sec id="s7_3"><title>3.3. 血清CRP及miR-223的临床预测价值分析</title><p>根据患者血清CPR和miR-223的表达水平，分别绘制ROC曲线，对其诊断价值进行评估。结果显示，血清CRP预测多发性骨折患者术后感染的曲线下面积(AUC)为0.812，灵敏度和特异度分别为76.9%和72.7%。血清miR-223的AUC为0.822，灵敏度和特异度分别为84.6%和74.5%。</p><p>此外，我们进一步使用分析了血清CRP和miR-223的联合诊断能力，结果显示，血清CRP和miR-150联合诊断患者术后感染的AUC为0.928，敏感度和特异度分别为96.4%和76.9%，均高于单个指标的预测结果(表3)。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Combined diagnostic value of serum CRP and miR-223 levels in prediction of the infections in the multiple fractur</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >指标</th><th align="center" valign="middle" >AUC</th><th align="center" valign="middle" >P值</th><th align="center" valign="middle" >95% CI</th><th align="center" valign="middle" >Cutoff值</th><th align="center" valign="middle" >灵敏度</th><th align="center" valign="middle" >特异度</th></tr></thead><tr><td align="center" valign="middle" >CRP</td><td align="center" valign="middle" >0.812</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.735~0.889</td><td align="center" valign="middle" >27.614</td><td align="center" valign="middle" >76.9%</td><td align="center" valign="middle" >72.7%</td></tr><tr><td align="center" valign="middle" >miR-223</td><td align="center" valign="middle" >0.822</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.745~0.899</td><td align="center" valign="middle" >0.665</td><td align="center" valign="middle" >84.6%</td><td align="center" valign="middle" >74.5%</td></tr><tr><td align="center" valign="middle" >CRP + miR-223</td><td align="center" valign="middle" >0.928</td><td align="center" valign="middle" >&lt;0.001</td><td align="center" valign="middle" >0.884~0.971</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >96.4%</td><td align="center" valign="middle" >76.9%</td></tr></tbody></table></table-wrap><p>表3. 血清CRP及miR-223水平联合诊断预测多发性骨折二次手术术后感染</p></sec></sec><sec id="s8"><title>4. 讨论</title><p>随着生活节奏的加快及交通工具的普及，创伤成为威胁人类安全的原因之一，由创伤带来的多发性骨折患者也逐渐增加 [<xref ref-type="bibr" rid="hanspub.39203-ref13">13</xref>]。多发性骨折患者术后常并发全身炎症反应综合征，是死亡率高的重要因素。临床上，对患者的术后感染情况进行准确评估，把握好手术时机，是改善多发性骨折患者预后的重中之重。近年来，血清标志物的筛选在多种疾病中被广泛关注和应用。与术后感染相关的血清标志物也引起了学者的兴趣，其中CRP和PCT是报道较多的两个血清标志物 [<xref ref-type="bibr" rid="hanspub.39203-ref14">14</xref>]。CRP是一种急性反应蛋白，是感染和炎性疾病的敏感标志物。感染和炎症发生后几小时CRP浓度会迅速上升，感染控制或炎症消除后，很快恢复正常。在临床上常通过检血清CRP浓度，判断患者的炎症程度，并对病毒或细菌感染进行初步判断。尽管CRP广泛应用于临床上的炎症反应评估，但是其诊断特异性不高。本研究对血清CRP在多发性骨折患者术后感染的预测价值进行了评估，结果发现，术后感染组的患者术前血清CRP显著高于非感染组，且ROC曲线结果证明，血清CRP对多发性骨折患者二次术后感染具有一定的诊断价值，这与前人的研究结果一致 [<xref ref-type="bibr" rid="hanspub.39203-ref15">15</xref>]。</p><p>miRNAs是一种或多或少由22个核苷酸组成的小的非编码RNA序列，通过与其3’未翻译区域互补配对，抑制特定mRNA靶点的翻译，从而在转录后水平上调控基因表达。MiR-223是高度保守的miRNA，之前的研究已经报道了大量miR-223的靶点，包括胰岛素样生长因子-1受体(IGF-1R)、单核细胞增强因子2C、stathmin 1、青蒿素和FOXO1A等 [<xref ref-type="bibr" rid="hanspub.39203-ref16">16</xref>]。近年来，miR-223在免疫和抗炎反应中的潜在作用被多番报道，被评定为有效的负性炎症调节因子。据报道，miR-223下调能够促进多种促炎因子的释放，如IL-6、IL-1β等 [<xref ref-type="bibr" rid="hanspub.39203-ref17">17</xref>]。miR-223在人类先天免疫中的作用也引起学者越来越多的关注 [<xref ref-type="bibr" rid="hanspub.39203-ref18">18</xref>]。研究表明，miR-223的异常表达与多种人类疾病的生理病理相关 [<xref ref-type="bibr" rid="hanspub.39203-ref19">19</xref>]。在脓毒症患者中，miR-223被报道在脓毒症患者的血清中低表达，与患者的感染状况密切相关 [<xref ref-type="bibr" rid="hanspub.39203-ref20">20</xref>]。本研究通过qRT-PCR对多发性骨折患者术前的血清miR-223水平进行了检测，结果发现，miR-223在术后感染组患者的血清中的表达水平显著低于非感染组，与以往的研究结果一致 [<xref ref-type="bibr" rid="hanspub.39203-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.39203-ref11">11</xref>]。此外，我们进一步绘制ROC曲线，对其诊断水平进行评估。结果表明，血清miR-223对多发性骨折患者术后是否发生感染有一定的预测价值，且其敏感度和特异度均高于血清CRP。</p><p>临床上，有时候单单用某一指标进行诊断，常存在灵敏度或特异度不足的问题，这时候，我们可以考虑联合试验 [<xref ref-type="bibr" rid="hanspub.39203-ref21">21</xref>]。所谓联合试验，即将两个及两个以上指标联合用于疾病诊断。本研究进一步评估了血清miR-223和CRP的联合诊断水平。结果表明，血清miR-223和CRP联合诊断的敏感度和特异度均高于单一指标的诊断结果。但是，本研究的样本量较小，对于miR-223在多发性骨折术后感染中的作用，需要在更大的样本中进行进一步的验证。</p><p>总之，本研究结合临床资料证实血清miR-223在多发性骨折术后感染的患者中低表达，可能是预测多发性骨折术后感染的一个潜在的生物标志物。血清miR-223和CRP联合诊断能够提高诊断的准确性。</p></sec><sec id="s9"><title>文章引用</title><p>王刚刚,张加良,臧 正,张海宁. 血清miR-223预测多发性骨折患者术后感染的临床价值分析Clinical Value Analysis of Serum miR-223 in Predicting Postoperative Infection of Multiple Fractures Patients[J]. 临床医学进展, 2020, 10(12): 2953-2959. https://doi.org/10.12677/ACM.2020.1012445</p></sec><sec id="s10"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.39203-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Maher, H. and Cai, X. (2020) Invited Commentary on: Clinical Efficacy of Surgical versus Conservative Treatment for Multiple Rib Fractures. International Journal of Surgery, 84, 24. &lt;br&gt;https://doi.org/10.1016/j.ijsu.2020.10.005</mixed-citation></ref><ref id="hanspub.39203-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Hayney, M.S., Henriquez, K.M., Barnet, J.H., et al. (2017) Serum IFN-Gamma-Induced Protein 10 (IP-10) as a Biomarker for Severity of Acute Respiratory Infection in Healthy Adults. Journal of Clinical Virology, 90, 32-37.  
&lt;br&gt;https://doi.org/10.1016/j.jcv.2017.03.003</mixed-citation></ref><ref id="hanspub.39203-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Choi, J.J. and McCarthy, M.W. (2018) Novel Applications for Serum Procalcitonin Testing in Clinical Practice. Expert Review of Molecular Diagnostics, 18, 27-34. &lt;br&gt;https://doi.org/10.1080/14737159.2018.1407244</mixed-citation></ref><ref id="hanspub.39203-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Vasileva, D. and Badawi, A. (2019) C-Reactive Protein as a Biomarker of Severe H1N1 Influenza. Inflammation Research, 68, 39-46. &lt;br&gt;https://doi.org/10.1007/s00011-018-1188-x</mixed-citation></ref><ref id="hanspub.39203-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Wang, S., Xie, Z. and Shen, Z. (2019) Serum Procalcitonin and C-Reactive Protein in the Evaluation of Bacterial Infection in Generalized Pustular Psoriasis. Anais Brasileiros de Dermatologia, 94, 542-548.  
&lt;br&gt;https://doi.org/10.1016/j.abd.2019.09.022</mixed-citation></ref><ref id="hanspub.39203-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Pai, P., Rachagani, S., Are, C., et al. (2013) Prospects of miRNA-Based Therapy for Pancreatic Cancer. Current Drug Targets, 14, 1101-1109. &lt;br&gt;https://doi.org/10.2174/13894501113149990181</mixed-citation></ref><ref id="hanspub.39203-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Wu, C., Wang, C., Guan, X., et al. (2014) Diagnostic and Prognostic Implications of a Serum miRNA Panel in Oesophageal Squamous Cell Carcinoma. PLoS ONE, 9, e92292. &lt;br&gt;https://doi.org/10.1371/journal.pone.0092292</mixed-citation></ref><ref id="hanspub.39203-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Dong, J., Liu, Y., Liao, W., et al. (2016) miRNA-223 Is a Potential Diagnostic and Prognostic Marker for Osteosarcoma. Journal of Bone Oncology, 5, 74-79. &lt;br&gt;https://doi.org/10.1016/j.jbo.2016.05.001</mixed-citation></ref><ref id="hanspub.39203-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Aziz, F. (2016) The Emerging Role of miR-223 as Novel Potential Diagnostic and Therapeutic Target for Inflammatory Disorders. Cellular Immunology, 303, 1-6. &lt;br&gt;https://doi.org/10.1016/j.cellimm.2016.04.003</mixed-citation></ref><ref id="hanspub.39203-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Cui, Y.L., Wang, B., Gao, H.M., et al. (2016) Interleukin-18 and miR-130a in Severe Sepsis Patients with Thrombocytopenia. Patient Preference and Adherence, 10, 313-319. &lt;br&gt;https://doi.org/10.2147/PPA.S95588</mixed-citation></ref><ref id="hanspub.39203-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, H., Mao, F., Shen, T., et al. (2017) Plasma miR-145, miR-20a, miR-21 and miR-223 as Novel Biomarkers for Screening Early-Stage Non-Small Cell Lung Cancer. Oncology Letters, 13, 669-676.  
&lt;br&gt;https://doi.org/10.3892/ol.2016.5462</mixed-citation></ref><ref id="hanspub.39203-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">中华人民共和国卫生部. 医院感染诊断标准: 现代实用医学[EB/OL]. 
http://www.nhc.gov.cn/wjw/gfxwj/201304/3660a9b180ce4c49910f516b30d3768f.shtml, 2001-11-07.</mixed-citation></ref><ref id="hanspub.39203-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Wang, H., Yu, H., Zhou, Y., et al. (2017) Traumatic Fractures as a Result of Falls in Children and Adolescents: A Retrospective Observational Study. Medicine (Baltimore), 96, e7879. &lt;br&gt;https://doi.org/10.1097/MD.0000000000007879</mixed-citation></ref><ref id="hanspub.39203-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ticinesi, A., Lauretani, F., Nouvenne, A., et al. (2017) C-Reactive Protein (CRP) Measurement in Geriatric Patients Hospitalized for Acute Infection. European Journal of Internal Medicine, 37, 7-12.  
&lt;br&gt;https://doi.org/10.1016/j.ejim.2016.08.026</mixed-citation></ref><ref id="hanspub.39203-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Govaert, G.A.M., Glaudemans, A., Ploegmakers, J.J.W., et al. (2018) Diagnostic Strategies for Posttraumatic Osteomyelitis: A Survey amongst Dutch Medical Specialists Demonstrates the Need for a Consensus Protocol. European Journal of Trauma and Emergency Surgery, 44, 417-426. &lt;br&gt;https://doi.org/10.1007/s00068-017-0783-9</mixed-citation></ref><ref id="hanspub.39203-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Chai, Y., Xue, H., Wu, Y., et al. (2018) MicroRNA-216b-3p Inhibits Lung Adenocarcinoma Cell Growth via Regulating PDZ Binding Kinase/T-LAK-Cell-Originated Protein Kinase. Experimental and Therapeutic Medicine, 15, 4822-4828. &lt;br&gt;https://doi.org/10.3892/etm.2018.6020</mixed-citation></ref><ref id="hanspub.39203-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Bozec, A., Zangari, J., Butori-Pepino, M., et al. (2017) MiR-223-3p Inhibits Angiogenesis and Promotes Resistance to Cetuximab in Head and Neck Squamous Cell Carcinoma. Oncotarget, 8, 57174-57186.  
&lt;br&gt;https://doi.org/10.18632/oncotarget.19170</mixed-citation></ref><ref id="hanspub.39203-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, X., Sun, L., Mu, T., et al. (2020) An HBV-Encoded miRNA Activates Innate Immunity to Restrict HBV Replication. Journal of Molecular Cell Biology, 12, 263-276. &lt;br&gt;https://doi.org/10.1093/jmcb/mjz104</mixed-citation></ref><ref id="hanspub.39203-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Fourdinier, O., Schepers, E., Metzinger-Le Meuth, V., et al. (2019) Serum Levels of miR-126 and miR-223 and Outcomes in Chronic Kidney Disease Patients. Scientific Reports, 9, Article No. 4477.  
&lt;br&gt;https://doi.org/10.1038/s41598-019-41101-8</mixed-citation></ref><ref id="hanspub.39203-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Wang, J.F., Yu, M.L., Yu, G., et al. (2010) Serum miR-146a and miR-223 as Potential New Biomarkers for Sepsis. Biochemical and Biophysical Research Communications, 394, 184-188. &lt;br&gt;https://doi.org/10.1016/j.bbrc.2010.02.145</mixed-citation></ref><ref id="hanspub.39203-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Simon, L., Gauvin, F., Amre, D.K., et al. (2004) Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases, 39, 206-217.  
&lt;br&gt;https://doi.org/10.1086/421997</mixed-citation></ref></ref-list></back></article>